Protocol for using Bamlanivimab & Etesevimab Anti-SARS-Cov-2 Monoclonal Antibodies

Protocol for using Bamlanivimab & Etesevimab Anti-SARS-Cov-2 Monoclonal Antibodies
Published on: 2021-11-03

Protocol for using Bamlanivimab & Etesevimab Anti-SARS-Cov-2 Monoclonal Antibodies

News & Update

Jan 1

Surveillance Bulletin Week 30, 2026

Acute Gastro Enteritis was the highest reported condition, accounting for 667 cases.

Read More
Surveillance Bulletin Week 30, 2026

Jan 1

Surveillance Bulletin Week 29, 2026

Acute Gastro Enteritis was the highest reported condition, accounting for 732 cases.

Read More
Surveillance Bulletin Week 29, 2026

Jan 1

Surveillance Bulletin Week 28, 2026

Acute Gastro Enteritis was the highest reported condition, accounting for 785 cases.

Read More
Surveillance Bulletin Week 28, 2026